Form 8-K - Current report:
SEC Accession No. 0001213900-24-070272
Filing Date
2024-08-16
Accepted
2024-08-16 16:30:10
Documents
15
Period of Report
2024-08-16
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0211486-8k_biomx.htm   iXBRL 8-K 35775
2 FORM OF CERTIFICATE OF AMENDMENT TO CERTIFICATE OF INCORPORATION OF BIOMX INC. ea021148601ex3-1_biomx.htm EX-3.1 6133
  Complete submission text file 0001213900-24-070272.txt   266232

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE phge-20240816.xsd EX-101.SCH 3805
4 XBRL DEFINITION FILE phge-20240816_def.xml EX-101.DEF 26681
5 XBRL LABEL FILE phge-20240816_lab.xml EX-101.LAB 36840
6 XBRL PRESENTATION FILE phge-20240816_pre.xml EX-101.PRE 25305
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0211486-8k_biomx_htm.xml XML 5935
Mailing Address 708 QUINCE ORCHARD RD SUITE 205 GAITHERSBURG MD 20878
Business Address 708 QUINCE ORCHARD RD SUITE 205 GAITHERSBURG MD 20878 844-972-0500
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

EIN.: 823364020 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38762 | Film No.: 241217088
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)